Hansen A P, Orskov H, Seyer-Hansen K, Lundbaek K
Br Med J. 1973 Sep 8;3(5879):523-4. doi: 10.1136/bmj.3.5879.523.
Preliminary studies indicate that somatostatin (SRIF, somatropin release inhibiting factor) can suppress exercise-induced plasma growth hormone rise in normal subjects as well as in diabetics.
初步研究表明,生长抑素(SRIF,生长激素释放抑制因子)可抑制正常受试者和糖尿病患者运动诱导的血浆生长激素升高。